Example of Journal of Biomedical Science format
Recent searches

Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format Example of Journal of Biomedical Science format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

Journal of Biomedical Science — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #8 of 246 up up by 36 ranks
Biochemistry (medical) #3 of 54 up up by 9 ranks
Clinical Biochemistry #6 of 113 up up by 23 ranks
Endocrinology, Diabetes and Metabolism #13 of 219 up up by 44 ranks
Molecular Biology #40 of 382 up up by 96 ranks
Cell Biology #35 of 279 up up by 82 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 376 Published Papers | 4288 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 18/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 5.0
SJR: 0.649
SNIP: 1.155
open access Open Access
recommended Recommended

American Thoracic Society

Quality:  
High
CiteRatio: 8.4
SJR: 2.469
SNIP: 1.181
open access Open Access

Bentham Science

Quality:  
Good
CiteRatio: 2.6
SJR: 0.302
SNIP: 0.546
open access Open Access

Springer

Quality:  
Good
CiteRatio: 5.5
SJR: 0.864
SNIP: 0.835

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

5.762

11% from 2018

Impact factor for Journal of Biomedical Science from 2016 - 2019
Year Value
2019 5.762
2018 5.203
2017 3.466
2016 2.799
graph view Graph view
table view Table view

11.4

36% from 2019

CiteRatio for Journal of Biomedical Science from 2016 - 2020
Year Value
2020 11.4
2019 8.4
2018 6.7
2017 5.6
2016 5.1
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 11% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 36% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

2.182

23% from 2019

SJR for Journal of Biomedical Science from 2016 - 2020
Year Value
2020 2.182
2019 1.767
2018 1.611
2017 1.302
2016 1.221
graph view Graph view
table view Table view

1.902

19% from 2019

SNIP for Journal of Biomedical Science from 2016 - 2020
Year Value
2020 1.902
2019 1.605
2018 1.318
2017 1.03
2016 1.012
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 23% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 19% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Journal of Biomedical Science

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Journal of Biomedical Science

Approved by publishing and review experts on SciSpace, this template is built as per for Journal of Biomedical Science formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 448 authors to write and format their manuscripts to this journal.

i
Last updated on
18 Jul 2020
i
ISSN
1606-8610
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder, G.E., Tinkham, M., Klapwijk, T.M.: Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 25(7), 4515–4532 (1982)

Top papers written in this journal

Journal Article DOI: 10.1007/BF02253360
Actions of melatonin in the reduction of oxidative stress
Russel J. Reiter1, Dun Xian Tan1, C. Osuna1, Eloisa Gitto1

Abstract:

Melatonin was discovered to be a direct free radical scavenger less than 10 years ago. Besides its ability to directly neutralize a number of free radicals and reactive oxygen and nitrogen species, it stimulates several antioxidative enzymes which increase its efficiency as an antioxidant. In terms of direct free radical scav... Melatonin was discovered to be a direct free radical scavenger less than 10 years ago. Besides its ability to directly neutralize a number of free radicals and reactive oxygen and nitrogen species, it stimulates several antioxidative enzymes which increase its efficiency as an antioxidant. In terms of direct free radical scavenging, melatonin interacts with the highly toxic hydroxyl radical with a rate constant equivalent to that of other highly efficient hydroxyl radical scavengers. Additionally, melatonin reportedly neutralizes hydrogen peroxide, singlet oxygen, peroxynitrite anion, nitric oxide and hypochlorous acid. The following antioxidative enzymes are also stimulated by melatonin: superoxide dismutase, glutathione peroxidase and glutathione reductase. Melatonin has been widely used as a protective agent against a wide variety of processes and agents that damage tissues via free radical mechanisms. read more read less

Topics:

Free radical scavenger (67%)67% related to the paper, Free-radical theory of aging (61%)61% related to the paper, Reactive oxygen species (60%)60% related to the paper, Radical (59%)59% related to the paper, Hydroxyl radical (59%)59% related to the paper
View PDF
1,074 Citations
open accessOpen access Journal Article DOI: 10.1186/S12929-019-0592-Z
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu1, Yu-Chyi Hwang1, I-Ju Liu1, Chi-Chiu Lee1, Han-Zen Tsai1, Hsin-Jung Li1, Han-Chung Wu1

Abstract:

It has been more than three decades since the first monoclonal antibody was approved by the United States Food and Drug Administration (US FDA) in 1986, and during this time, antibody engineering has dramatically evolved. Current antibody drugs have increasingly fewer adverse effects due to their high specificity. As a result... It has been more than three decades since the first monoclonal antibody was approved by the United States Food and Drug Administration (US FDA) in 1986, and during this time, antibody engineering has dramatically evolved. Current antibody drugs have increasingly fewer adverse effects due to their high specificity. As a result, therapeutic antibodies have become the predominant class of new drugs developed in recent years. Over the past five years, antibodies have become the best-selling drugs in the pharmaceutical market, and in 2018, eight of the top ten bestselling drugs worldwide were biologics. The global therapeutic monoclonal antibody market was valued at approximately US$115.2 billion in 2018 and is expected to generate revenue of $150 billion by the end of 2019 and $300 billion by 2025. Thus, the market for therapeutic antibody drugs has experienced explosive growth as new drugs have been approved for treating various human diseases, including many cancers, autoimmune, metabolic and infectious diseases. As of December 2019, 79 therapeutic mAbs have been approved by the US FDA, but there is still significant growth potential. This review summarizes the latest market trends and outlines the preeminent antibody engineering technologies used in the development of therapeutic antibody drugs, such as humanization of monoclonal antibodies, phage display, the human antibody mouse, single B cell antibody technology, and affinity maturation. Finally, future applications and perspectives are also discussed. read more read less

Topics:

Humanized antibody (53%)53% related to the paper
View PDF
1,025 Citations
Journal Article DOI: 10.1007/S11373-004-8183-7
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

Abstract:

Human mesenchymal stem cells (MSCs) were evaluated for their ability to activate allogeneic T cells in cell mixing experiments Phenotypic characterization of MSCs by flow cytometry showed expression of MHC Class I alloantigens, but minimal expression of Class II alloantigens and costimulatory molecules, including CD80 (B7-1),... Human mesenchymal stem cells (MSCs) were evaluated for their ability to activate allogeneic T cells in cell mixing experiments Phenotypic characterization of MSCs by flow cytometry showed expression of MHC Class I alloantigens, but minimal expression of Class II alloantigens and costimulatory molecules, including CD80 (B7-1), CD86 (B7-2), and CD40 T cells purified from peripheral blood mononuclear cells (PBMCs) did not proliferate to allogeneic MSCs Lack of response was not due to a deficiency of costimulation, since retroviral transduction of MSCs with either B7-1 or B7-2 costimulatory molecules did not result in lymphoproliferation Although these results suggested that MSCs were immunologically inert or potentially tolerogenic, T cells cultured with MSCs produced IFN-γ and displayed secondary kinetics to restimulation with PBMCs, indicating alloantigen priming rather than tolerance induction by the MSCs To determine whether MSCs suppressed alloreactive T cells, MSCs were added to primary mixed lymphocyte reaction (MLR) cultures MSCs suppressed cell proliferation when added at the initiation of culture or when added to an ongoing MLR culture Suppression was dose-dependent, genetically unrestricted, and occurred whether or not MSCs were pretreated with IFN-γ MSCs in transwell chambers suppressed primary MLR cultures, indicating that suppression was mediated by soluble molecules Analysis of cytokines in suppressed MLR cultures demonstrated up-regulation of IFN-γ and IL-10, and down-regulation of TNF-α production relative to control cultures We conclude that MSCs can initiate activation of alloreactive T cells, but do not elicit T cell proliferative responses due to active suppressive mechanisms read more read less

Topics:

T cell (59%)59% related to the paper, CD86 (57%)57% related to the paper, CD80 (57%)57% related to the paper, Mesenchymal stem cell (56%)56% related to the paper, CD40 (54%)54% related to the paper
View PDF
565 Citations
Journal Article DOI: 10.1007/BF02256058
Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

Abstract:

We have characterized adhesion molecules on the surface of multipotential human mesenchymal stem cells (hMSCs) and identified molecules whose ligands are present on mature hematopoietic cells. Flow cytometric analysis of hMSCs identified the expression of integrins: α1, α2, α3, α5, α6, αv, β1, β3, and β4, in addition to ICAM-... We have characterized adhesion molecules on the surface of multipotential human mesenchymal stem cells (hMSCs) and identified molecules whose ligands are present on mature hematopoietic cells. Flow cytometric analysis of hMSCs identified the expression of integrins: α1, α2, α3, α5, α6, αv, β1, β3, and β4, in addition to ICAM-1, ICAM-2, VCAM-1, CD72, and LFA-3. Exposure of hMSCs to IL-1α, TNFα or IFNγ up-modulated ICAM-1 surface expression, whereas only IFNγ increased both HLA-class I and -class II molecules on the cell surface. Whole cell-binding assays between the hMSCs and hematopoietic cell lines showed that T lymphocytic lines bound hMSCs with higher affinity than lines of either B lymphocytes or those of myeloid lineage. Experiments using autologous T lymphocytes isolated from peripheral blood mononuclear cells showed that hMSCs exhibited increased affinity for activated T-lymphocytes compared to resting T cells by quantitative whole cell binding and rosetting assays. Flow cytometric analysis of rosetted cells demonstrated that both CD4+ and CD8+ cells bound to hMSCs. To determine the functional significance of these findings, we tested the ability of hMSCs to present antigen to T lymphocytes. hMSCs pulsed with tetanus toxoid stimulated proliferation and cytokine production (IL-4, IL-10, and IFNγ) in a tetanus-toxoid-specific T cell line. Maximal cytokine production correlated with maximal antigen-dependent proliferation. These data demonstrate physiological outcome as a consequence of interactions between hMSCs and human hematopoietic lineage cells, suggesting a role for hMSCs in vivo to influence both hematopoietic and immune function(s). read more read less

Topics:

T cell (58%)58% related to the paper, Cell adhesion (53%)53% related to the paper, Antigen presentation (53%)53% related to the paper, Mesenchymal stem cell (53%)53% related to the paper, Cell adhesion molecule (52%)52% related to the paper
546 Citations
open accessOpen access Journal Article DOI: 10.1186/S12929-019-0568-Z
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen1, Yucen Song1, Wei Du1, Longlong Gong2, Haocai Chang2, Zhengzhi Zou2

Abstract:

In many solid tumor types, tumor-associated macrophages (TAMs) are important components of the tumor microenvironment (TME). Moreover, TAMs infiltration is strongly associated with poor survival in solid tumor patients. In this review, we describe the origins of TAMs and their polarization state dictated by the TME. We also s... In many solid tumor types, tumor-associated macrophages (TAMs) are important components of the tumor microenvironment (TME). Moreover, TAMs infiltration is strongly associated with poor survival in solid tumor patients. In this review, we describe the origins of TAMs and their polarization state dictated by the TME. We also specifically focus on the role of TAMs in promoting tumor growth, enhancing cancer cells resistance to chemotherapy and radiotherapy, promoting tumor angiogenesis, inducing tumor migration and invasion and metastasis, activating immunosuppression. In addition, we discuss TAMs can be used as therapeutic targets of solid tumor in clinics. The therapeutic strategies include clearing macrophages and inhibiting the activation of TAMs, promoting macrophage phagocytic activity, limiting monocyte recruitment and other targeted TAMs therapies. read more read less

Topics:

Tumor microenvironment (56%)56% related to the paper
View PDF
515 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Journal of Biomedical Science.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Journal of Biomedical Science in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Journal of Biomedical Science guidelines and auto format it.

2. Do you follow the Journal of Biomedical Science guidelines?

Yes, the template is compliant with the Journal of Biomedical Science guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Journal of Biomedical Science?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Journal of Biomedical Science citation style.

4. Can I use the Journal of Biomedical Science templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Journal of Biomedical Science.

5. Can I use a manuscript in Journal of Biomedical Science that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Journal of Biomedical Science that you can download at the end.

6. How long does it usually take you to format my papers in Journal of Biomedical Science?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Journal of Biomedical Science.

7. Where can I find the template for the Journal of Biomedical Science?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Biomedical Science's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Journal of Biomedical Science's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Journal of Biomedical Science an online tool or is there a desktop version?

SciSpace's Journal of Biomedical Science is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Journal of Biomedical Science?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Journal of Biomedical Science?”

11. What is the output that I would get after using Journal of Biomedical Science?

After writing your paper autoformatting in Journal of Biomedical Science, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Journal of Biomedical Science's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Journal of Biomedical Science?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Journal of Biomedical Science. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Journal of Biomedical Science?

The 5 most common citation types in order of usage for Journal of Biomedical Science are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Journal of Biomedical Science?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Biomedical Science's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Journal of Biomedical Science in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Journal of Biomedical Science Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Journal of Biomedical Science formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template